| Vaccine-induced COVID-19 mimicry syndrome E Kowarz, L Krutzke, M Külp, P Streb, P Larghero, J Reis, S Bracharz, ... Elife 11, 2022 | 134 | 2022 |
| Generation of a sleeping beauty transposon-based cellular system for rapid and sensitive screening for compounds and cellular factors limiting SARS-CoV-2 replication M Widera, A Wilhelm, T Toptan, JM Raffel, E Kowarz, F Roesmann, ... Frontiers in microbiology 12, 701198, 2021 | 31 | 2021 |
| The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t (4; 11) acute lymphoblastic leukemia M Külp, AL Siemund, P Larghero, A Dietz, J Alten, G Cario, C Eckert, ... Iscience 25 (7), 2022 | 5 | 2022 |
| mimicry syndrome., 2022, 11, p. e74974 E Kowarz, L Krutzke, M Külp, P Streb, P Larghero, J Reis, S Bracharz, ... DOI: https://doi. org/10.7554/eLife 74974, 19 | 5 | 19 |
| The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome M Külp, P Larghero, J Alten, G Cario, C Eckert, A Caye-Eude, H Cavé, ... Leukemia 37 (6), 1216-1233, 2023 | 1 | 2023 |
| Targeted Next Generation Sequencing Reveals a Third Breakpoint Cluster Region and New Partner Genes in the KMT2A Recombinome C Meyer, P Larghero, B Lopes, A Caye-Eude, H Cavé, M Külp, MJ Smith, ... Blood 138, 3327, 2021 | 1 | 2021 |
| Generation of a Sleeping Beauty transposon-based cellular system for rapid and sensitive identification of SARS-CoV-2 host dependency and restriction factors M Widera, A Wilhelm, T Toptan, JM Raffel, E Kowarz, F Roesmann, ... bioRxiv, 2021.04. 27.441606, 2021 | 1 | 2021 |
| Single Cell Analysis Identifies Expression of PD-L2 on Human Bone Marrow Hematopoietic Stem Cells T Schmachtel, M Külp, W Yu, H Komic, C Simoes, MS Nilsson, F Prosper, ... Blood 142, 2671, 2023 | | 2023 |
| P337: IKZF1 DELETIONS IN B-ALL: FROM ITS GENETIC BASIS TO DIAGNOSTIC ENHANCEMENT BA Lopes, C Meyer, H Bouzada, M Külp, ALT Maciel, P Larghero, ... HemaSphere 7 (S3), e5507229, 2023 | | 2023 |
| The recombinome of IKZF1 deletions in B-cell precursor ALL BA Lopes, C Meyer, H Bouzada, M Külp, ALT Maciel, P Larghero, ... Leukemia 37 (8), 1727-1731, 2023 | | 2023 |
| The recombinome of IKZF1 deletions in B-ALL B Lopes, C Meyer, H Bouzada, M Külp, AL Maciel, P Larghero, T Barbosa, ... | | 2023 |
| 3109–IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A:: AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA M Külp, P Larghero, J Alten, G Cario, C Eckert, A Caye-Eude, H Cavé, ... Experimental Hematology 124, S104, 2023 | | 2023 |
| EGR-mediated relapse mechanisms in infant t (4; 11) acute lymphoblastic leukemia M Külp Dissertation, Frankfurt am Main, Johann Wolfgang Goethe-Universität, 2022, 2022 | | 2022 |
| Co-culture of primary human T cells with leukemia cells to measure regulatory T cell expansion M Külp, L Diehl, H Bonig, R Marschalek STAR protocols 3 (3), 101661, 2022 | | 2022 |
| The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t (4; 11) ALL M Külp, P Larghero, A Dietz, G Cario, C Eckert, A Caye-Eude, ... Klinische Pädiatrie 234 (03), 0003, 2022 | | 2022 |
| Implication of ICOSLG on Relapse in Infant T (4; 11) Acute Lymphoblastic Leukemia M Külp, AL Siemund, C Meyer, P Larghero, A Dietz, J Alten, G Cario, ... Blood 138 (Supplement 1), 3481-3481, 2021 | | 2021 |
